Organic halides (R-X) are prevalent structural motifs in pharmaceutical molecules and key building blocks for the synthesis of fine chemicals. Although a number of routes are available in the literature for the synthesis of organic halides, these methods often require stoichiometric additives or oxidants, metal catalysts, leaving or directing groups, or toxic halogenating agents. In addition, the necessity of employing different, often tailor-made, catalytic systems for each type of substrate also limits the applicability of these methods. Herein, we report a clean halogenation by electrochemical oxidation with NaX/HX. A series of organic halides were prepared under metal catalyst-and exogenousoxidant-free reaction conditions. It is worth noting that this reaction has a broad substrate scope; various heteroarenes, arenes, alkenes, alkynes, and even aliphatic hydrocarbons could be applied. Most importantly, the reaction could also be performed on a 200-mmol scale with the same efficiency (86%, 50.9 g pure product).
Benzo[4,5]imidazo[2,1-a]isoquinolin-6(5H)-one derivatives are
prevalent in many synthetic intermediates,
pharmaceuticals, and organic materials. Herein, we develop a Mn-catalyzed
electrochemical radical cascade cyclization reaction that uses electricity
as the primary energy input to promote the reaction, leading to a
series of benzo[4,5]imidazo[2,1-a]isoquinolin-6(5H)-one derivatives under exogenous-oxidant-free conditions.
It is worth noting that this electrochemical method can not only realize
the synthesis of benzo[4,5]imidazo[2,1-a]isoquinolin-6(5H)-one derivatives but also provides a new strategy for
generating alkyl radicals from alkylboronic acids.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.